The spatial organization of a cell includes lipid membrane-based compartments and an emerging class of subcellular structures collectively described as biomolecular condensates 1 . Lipid membranes act as a biologically active scaffold to concentrate signaling molecules in multiple signal transduction pathways that regulate normal physiology and pathologic conditions such as cancer 2 . Notably, receptor tyrosine kinase (RTK)-mediated RAS GTPase/MAP kinase (MAPK) pathway signaling is thought to occur exclusively from lipid membrane compartments in mammalian cells 3, 4 . Here, we uncover a membraneless, protein granule-based subcellular structure that can organize RTK/RAS/MAPK signaling. Chimeric (fusion) oncoproteins involving certain RTKs including ALK and RET undergo de novo assembly into cytoplasmic protein granules that locally concentrate the RAS activating complex GRB2/SOS1 and activate RAS in a lipid membrane-independent manner to initiate MAPK signaling. We show that formation of higher-order membraneless protein granules is both necessary and sufficient for RAS/MAPK signaling output in cells. These large-scale protein assemblies are functionally distinct from lower-order oligomerization of cytoplasmic RTK fusion oncoproteins. Our findings reveal membraneless, higher-order cytoplasmic protein assembly as a subcellular platform to
activate RAS GTPases and a distinct principle by which cells can organize kinase-mediated oncogenic signaling.
Main 1 RTK/RAS/MAPK signaling is broadly important in regulating the proliferation and survival of 2 normal human cells and is often hyper-activated through various mechanisms in human cancer 5 . 3 Evidence of local RAS protein clustering in plasma membrane (PM) microdomains 6, 7 and recent 4
reports that the PM resident T-cell receptor and associated proteins undergo phase separation in 5 the presence of lipid bilayers highlight the importance of physical compartmentalization of 6 signaling events 8, 9 . Biomolecular condensates are an emerging mechanism of subcellular 7 compartmentalization through primarily protein-based membraneless organelles such as P- 8 bodies, nucleoli and stress granules 10, 11 . Though connections between aberrant transcription 9
factor condensates and cancer have been proposed 12, 13 , the functional role of biomolecular 10 condensates in oncogenic signaling and cancer pathogenesis remains to be defined . 11 Prominent examples of oncogenic RTK/RAS/MAPK signaling in cancer include chromosomal 12 rearrangements involving RTKs such as anaplastic lymphoma kinase (ALK) or rearranged 13 during transfection (RET), which generate chimeric (fusion) oncoproteins that are validated 14 therapeutic targets across multiple cancer subtypes 14, 15 . Virtually all oncogenic ALK fusion 15 proteins retain the intracellular domain, which includes the kinase, but lack the native 16 transmembrane domain 14 . We previously discovered that the echinoderm microtubule-associated 17 protein-like 4 (EML4)-ALK fusion oncoprotein that is present recurrently in lung and other 18 cancer subtypes is exquisitely dependent upon RAS GTPase activation and downstream 19 RAF/MEK/ERK (MAPK pathway) signaling for its oncogenic output 16 . We and other groups 20 showed that EML4-ALK is not localized to the PM, but instead to intracellular, punctate 21 cytoplasmic structures of unknown identity 16, 17 . This specific intracellular localization is 22 essential for EML4-ALK to activate RAS and downstream MAPK signaling 16 . Neither the 23 biophysical or biochemical nature of these cytoplasmic structures nor the mechanism through 24 which they promote oncogenic signaling is clear. 25
To address these knowledge gaps, we focused our initial study on EML4-ALK variant 1, the 26 most common oncogenic form in human cancers 18 . Given the well-established requirement for 27 lipid membranes in mediating RAS GTPase activation 4, 19 , we first tested whether EML4-ALK 28 localizes to an intracellular lipid membrane-containing structure. Live-cell imaging in a non-29
transformed human bronchial epithelial cell line (Beas2B) expressing fluorescent protein-tagged 30
EML4-ALK showed no significant colocalization of EML4-ALK cytoplasmic puncta with 31 plasma or intracellular membranes as marked by a membrane intercalating dye, or with a panel 32
of established protein markers labeling canonical intracellular lipid-containing organelles 20 
33
(Extended Data Fig. 1 ). Additionally, subcellular fractionation in patient-derived cancer cell lines 34 expressing endogenous EML4-ALK protein produced an EML4-ALK fractionation pattern 35 unaffected by membrane-solubilizing detergents, which was distinct from the pattern of PM 36 spanning (epidermal growth factor receptor, EGFR) or internal membrane proteins (calnexin and  37 early endosome antigen 1, EEA1), yet similar to that of a well-known cytoplasmic protein 38 granule constituent (the P-body protein de-capping mRNA 1B, DCP1B 21 ) ( Fig. 1a , b, and 39
Extended Data Fig. 2 ). We confirmed by fluorescence microscopy that EML4-ALK puncta do 40 not colocalize with the two known biomolecular condensates in the cytoplasm, P-bodies and 41 stress granules, suggesting EML4-ALK forms distinct membraneless cytoplasmic granules 42 (Extended Data Fig. 1 ). We validated by immunofluorescence (IF) the similar presence of  43 EML4-ALK cytoplasmic granules in patient-derived cancer cells (H3122) that endogenously 44 express this variant ( Fig. 1c ) and in human bronchial epithelial cells (Beas2B) expressing FLAG-45 tagged EML4-ALK (Extended Data Fig. 3a ), verifying that these granules were not the result of 46 artificial expression or fluorescent protein-mediated multimerization 22 . 47
We further investigated the biophysical nature of EML4-ALK cytoplasmic granules using a suite 48 of established cellular assays to characterize biomolecular condensates 23, 24 . During live-cell 49 imaging, no fission or fusion of EML4-ALK granules was observed in spite of occasional 50 granule collisions (Video S1), which is in contrast to the expected behaviors for liquid-like 51 granules. Unlike DCP1B-labelled P-bodies, we found that EML4-ALK granules mostly persist 52 after hexanediol treatment, which disrupts many liquid-like condensates 25 (Extended Data Fig.  53 4). Super-resolution imaging by Structured Illumination Microscopy (SIM) revealed that the 54 EML4-ALK granules exhibit porous and curvilinear features that are distinct from the more 55 uniform appearance of liquid-like granules ( Fig. 1d ) 10, 23 . Moreover, fluorescence recovery after 56 photo-bleaching (FRAP) showed an overall low fraction of exchange of EML4-ALK between 57 the granules and the surrounding cytosol ( Fig. 1e ). This recovery fraction was heterogeneous 58 amongst granules, varying from 40% to negligible recovery at 1 minute, possibly reflecting an 59 ongoing aging process as maturing granules adopt increasingly solid-like states 24 . EML4-ALK 60 granules are also not disrupted by RNase A, in contrast to ribonucleoprotein granules like the P-61 body (Extended Data Fig. 5 ). Taken together, the data indicate EML4-ALK cytoplasmic granules 62 are protein-based instead of RNA-protein-based and demonstrate biophysical properties that are 63 more solid than liquid-like. 64
To uncover the connection between EML4-ALK granules and RAS activation, we created a 65 library of gene-edited Beas2B cell lines by introducing a split mNeonGreen21-10/11 tag (mNG2) at 66 the endogenous locus of canonical adaptor and effector proteins in the RTK/RAS/MAPK 67 signaling pathway, including GRB2, GAB1, SOS1, and RAS GTPases (H/N/K isoforms) 26 . This 68 suite of isogenic cell lines avoids potential biases that can arise when overexpressing labeled 69 proteins or fixing and permeabilizing cells for immunofluorescence. In this set of cell lines, we 70 found that expression of EML4-ALK specifically re-localized key upstream RAS pathway 71 proteins, including GRB2, GAB1, and SOS1, from a mainly diffusive cytosolic pattern to the 72 discrete EML4-ALK granules ( Fig. 1f , g), but not to the PM. This is distinct from the pattern of 73 PM re-localization seen in the control case of expressing an oncogenic form of the 74 transmembrane RTK EGFR (Extended Data Fig. 6 ). Treatment with the ALK kinase inhibitor 75 crizotinib for 24 hours substantially reduced the recruitment of these adaptor proteins, indicating 76 that this process requires ALK kinase activation ( Fig. 1h ). We orthogonally confirmed 77 recruitment of the key adaptor, GRB2, both in patient-derived cancer cells and through dual 78 expression of EML4-ALK and GRB2 in Beas2B cells ( Fig. 1c and Extended Data Fig. 3b ). 79
Additionally, we observed a low and heterogeneous FRAP recovery behavior for GRB2 at the 80 EML4-ALK protein granules, similar to that of EML4-ALK itself (Extended Data Fig. 7 ). 81
Our imaging and biochemical data prompted the unanticipated hypothesis that RAS GTPase 82 activation may occur via a non-lipid membrane-containing structure (e.g. EML4-ALK 83 membraneless protein granules), potentially through a cytosolic pool of RAS that is known to 84 exist but with unclear functional significance 27 . We first confirmed RAS protein expression in 85 the cytosol where the EML4-ALK granules reside, in addition to lipid membrane subcellular 86 compartments (Extended Data Fig. 8 ). Next, we directly tested whether cytosolic RAS can 87 become activated in a lipid membrane-independent manner by EML4-ALK protein granules. We 88 utilized established mutant forms of RAS (KRAS-C185S, H/NRAS-C186S) that abrogate lipid 89 membrane targeting and are retained exclusively in the cytosol 19 . While the expression of either 90 EML4-ALK or the PM-localized oncogenic EGFR increased RAS-GTP levels ( Fig. 2a and 91
Extended Data Fig. 9 ), only EML4-ALK increased RAS-GTP levels of cytosolic RAS mutants 92 ( Fig. 2b and Extended Data Fig. 9 ). Furthermore, inhibition of EML4-ALK with crizotinib in 93 H3122 patient-derived cancer cells suppressed not only wild-type RAS-GTP levels, but also the 94 levels of GTP-bound, cytosolic KRAS-C185S ( Fig. 2c, d) . Control experiments treating a 95 distinct patient-derived cancer cell line HCC827 expressing endogenous oncogenic EGFR (PM-96 localized) with an established EGFR inhibitor 28 confirmed suppression of wild-type RAS-GTP 97 levels but showed no effect on KRAS-C185S RAS-GTP levels (Extended Data Fig. 10 ). These 98 findings demonstrate the specificity of cytosolic RAS activation by oncogenic EML4-ALK. 99
Lastly, to determine whether EML4-ALK cytoplasmic granules display evidence of local RAS 100 activation (i.e. RAS-GTP), we used an established tandem GFP-RBD (RAS-binding domain) 101
live-cell reporter given its high affinity binding to RAS-GTP and sensitivity for detection of 102 endogenous RAS activation 29 . When expressed alone, the RAS-GTP reporter displayed 103 homogenous localization in the cytosol and enrichment in the nucleoplasm, as previously 104 described 30 ( Fig. 2e ). As a positive control, expression of oncogenic KRAS in Beas2B cells led 105
to re-localization of the RAS-GTP reporter to the PM (Extended Data Fig. 11 ). In EML4-ALK 106 expressing cells, we observed robust enrichment of the RAS-GTP reporter at EML4-ALK 107 cytoplasmic protein granules ( Fig. 2e , f) and not at the PM. Co-expression of a dominant 108 negative RAS (RASN17) 31 that interferes with RAS activation (GTP-loading) decreased 109 colocalization of the RAS-GTP reporter at EML4-ALK granules, as did introduction of 110 mutations into the GFP-RBD reporter (R59A/N64D) that decrease affinity for RAS-GTP 29 (Fig.  111 2f). The collective findings show that local RAS activation and accumulation of RAS-GTP 112 occurs at membraneless EML4-ALK cytoplasmic protein granules. 113
We next tested whether downstream MAPK signaling output is dependent on EML4-ALK 114 cytoplasmic protein granules by investigating the molecular determinants of de novo granule 115 formation. The EML4 portion of the chimeric EML4-ALK oncoprotein contains an N-terminal 116 trimerization domain (TD) and a truncated tandem atypical WD-propeller in EML4 protein 117 (TAPE) domain 18 (Fig. 3a) . Deletion of the TD or the hydrophobic EML protein (HELP) motif 118 in the propeller domain disrupted protein granule formation, resulting instead in a diffuse 119 cytosolic distribution of EML4-ALK labeled by either fluorescent protein or FLAG-tag (Fig. 3b , 120 c and Extended Data Fig. 12 ). ∆TD or ∆HELP mutants of EML4-ALK demonstrated loss of 121 ALK trans-phosphorylation and GRB2 interaction ( Fig. 3d and Extended Data Fig. 13 ) and 122 impaired RAS/MAPK activation ( Fig. 3e and Extended Data Figs. 13, 14) . These data implicate 123 de novo protein granule formation mediated by the EML4 portion of the fusion protein as critical 124
for productive RAS/MAPK signaling. We also observed disrupted granule formation and absent 125 RAS/MAPK signaling with an established kinase-deficient mutant (K589M) form of EML4-126 ALK (Fig. 3b -e and Extended Data Figs. [12] [13] [14] , an effect that may be due to phosphorylation 127 events regulating EML4-ALK granule formation, as shown in other protein granule systems 32, 33 . 128
Our findings prompted a model in which higher-order clustering of an RTK in membraneless 129 cytoplasmic protein granules is sufficient to organize activation of RAS/MAPK signaling. To 130 directly test this hypothesis, we utilized the HOtag method developed recently to enable forced 131 protein granule formation through multivalent interactions 34 (Extended Data Fig. 15 ). HOtag-132 induced cytoplasmic granule formation of either the ∆TD or ∆HELP mutants of EML4-ALK 133 locally recruited GRB2 (Fig. 3f, g) , increased RAS-GTP levels (Extended Data Fig. 14) and 134 restored RAS/MAPK signaling (Fig. 3h, i) . As an important negative control, HOtag-forced 135 clustering of the kinase-deficient EML4-ALK did not promote GRB2 recruitment or 136 RAS/MAPK signaling (Fig. 3f-i and Extended Data Fig. 14) . The findings highlight the dual 137 importance of cytoplasmic protein granule formation and intact kinase activity for productive 138
signaling. We also directly tested the role of protein granule formation on cytosolic RAS 139 activation. Compared to wild-type EML4-ALK, the ∆TD mutant that is expressed diffusely in 140 the cytosol demonstrated substantially reduced levels of activated (GTP-bound) cytosolic KRAS-141 C185S, which could be restored through HOtag-forced clustering (Extended Data Fig. 16 ). 142
Collectively, our data show that membraneless EML4-ALK cytoplasmic protein granules can 143 spatially concentrate, organize, and initiate RAS/MAPK pathway signaling events. 144
We tested the generality of this model. First, multiple variants of EML4-ALK have been 145 described in cancer patients 18 , all comprising the intracellular domain of ALK (but not its 146 transmembrane domain) fused to N-terminal fragments of EML4 of varying lengths (Fig. 4a ). 147
We demonstrated that another recurrent form of oncogenic EML4-ALK (variant 3), which 148 contains a further truncation of the TAPE domain but retains the TD 18 , also formed cytoplasmic 149 granules that locally recruited GRB2 and increased RAS/MAPK signaling ( Fig. 4b-d and 150
Extended Data Figs. 17, 18) . In contrast, EML4-ALK variant 5, which lacks the entire TAPE 151 domain of EML4, did not form protein granules and demonstrated significantly less RAS/MAPK 152 signaling compared to the protein granule-forming EML4-ALK variants 1 and 3 (Fig. 4b-d and 153
Extended Data Fig. 18 ). HOtag-forced clustering of EML4-ALK variant 5 augmented 154 RAS/MAPK signaling (Extended Data Fig. 19 ). Consistent with the presence of a TD in all 155 EML4-ALK variants, the granule-forming EML4-ALK variants (1 and 3) and the non-granule-156 forming variant 5 were each capable of self-association in co-immunoprecipitation experiments 157
(Extended Data Fig. 20) . These results suggest a functional difference in terms of RAS/MAPK 158 signaling output between higher-order protein granule formation (EML4-ALK variants 1 and 3) 159
and lower-order self-association through oligomerization (EML4-ALK variant 5). 160
Next, as a proof-of-principle for the functional importance of higher-order protein assembly, we 161 engineered an intracellular EGFR (iEGFR) protein lacking the native extracellular and 162 transmembrane domains. This iEGFR is similar to naturally-occurring truncated forms of this 163 RTK and others 35, 36 and is distributed diffusely in the cytoplasm and nucleus when expressed 164 alone (Fig. 4e ). HOtag forced clustering of iEGFR recruited GRB2 and increased RAS/MAPK 165 signaling in a kinase-dependent manner, analogous to oncogenic ALK (Fig. 4e, f) . 166
Finally, we studied another oncogenic RTK, RET, that also undergoes multiple distinct gene 167 rearrangements in human cancer, leading to the elimination of the extracellular and 168 transmembrane domains from the fusion oncoprotein 15 . The recurrent fusion oncoprotein 169 CCDC6-RET formed de novo cytoplasmic protein granules (Fig. 4g, h) which did not 170 demonstrate PM localization or colocalize with intracellular lipid-containing organelles or a 171 lipid-intercalating dye (Extended Data Fig. 21 ). CCDC6-RET cytoplasmic protein granules 172 recruited GRB2 ( Fig. 4h ) and locally enriched RAS-GTP as measured by the tandem GFP-RBD 173 reporter (Extended Data Fig. 22a ), resulting in increased RAS activation and downstream MAPK 174 signaling ( Fig. 4i and Extended Data Fig. 22b, c) . Structure-function studies showed that a 175 CCDC6-RET mutant lacking the coiled-coil domain in the CCDC6 component abrogated 176 granule formation (Extended Data Fig. 23 ) and reduced RAS/MAPK activation ( Fig. 4i and  177 Extended Data Fig. 22b, c) . A kinase-deficient (K147M) mutant form of CCDC6-RET still 178 formed cytoplasmic protein granules but was unable to recruit GRB2 (Extended Data Fig. 24 ) or 179 activate RAS/MAPK signaling ( Fig. 4i and Extended Data Fig. 22b, c) . These results reinforce 180 the dual importance of cytoplasmic protein granules and kinase activity in driving oncogenic 181 RTK/RAS/MAPK signaling. The data also reveal differences between EML4-ALK and CCDC6-182
RET in the dependence on kinase activity for granule formation. 183
Collectively, our findings show that membraneless cytoplasmic protein granules coordinate RAS 184 activation in a lipid membrane-independent manner in mammalian cells and that de novo 185 formation of these biomolecular condensates may represent a general mechanism for organizing 186 oncogenic kinase signaling in cancer. Oncogenic kinase fusion proteins often contain 187 multimerization domains in the non-kinase fusion partner which are known to be important for 188
self-association and oncogenic signaling 37, 38 HOtag-EML4-ALK form EML4 protein (TAPE) domain, and ALK kinase domain. b, Live-cell confocal imaging of mTagBFP2::EML4-ALK (denoted as WT for wild-type EML4-ALK) or kinase-deficient (K589M), DTD or DHELP mutants in human epithelial cell line Beas2B. c, Quantification of percentage of cells with granules. At least 75 cells were scored over 3 independent replicates. d, Anti-FLAG co-immunoprecipitation of FLAG-tagged wild-type (WT) EML4-ALK or respective mutants expressed in 293T cells, followed by Western blotting to assess GRB2 binding. EV denotes empty vector control, images representative of at least 3 independent experiments. e, Quantification of Western blotting upon expression of EML4-ALK or respective mutants in 293T cells. pERK levels were normalized to total ERK and then displayed relative to wild-type EML4-ALK sample which was set to 100, N = 4. f, Live-cell confocal imaging of HOtag-mTagBFP2::EML4-ALK DTD, DHELP, and K589M mutants in Beas2B cells with endogenous mNG2-tagging of GRB2. White arrows indicate representative HOtag-EML4-ALK DTD or DHELP protein granules with local enrichment of GRB2 (multiple non-highlighted granules also show colocalization between HOtag EML4-ALK mutants and GRB2). g, Quantification of percent colocalization between HOtag protein granules of EML4-ALK mutants and GRB2. N = 130 total cells for each condition over 3 independent experiments. h, i, Western blotting upon expression of wild-type EML4-ALK or respective mutants +/-HOtag in 293T cells. For quantification, pERK levels were normalized to total ERK and then displayed relative to wildtype EML4-ALK sample which was set to 100, N = 5. For all panels, error bars represent ± SEM, * denotes p < 0.05, n.s. denotes non-significant comparison, one-way ANOVA (c, e, g) or paired t-test (i). 
